Letter to the Editor
Split Viewer
Blood Res 2015; 50(2):
Published online June 25, 2015
https://doi.org/10.5045/br.2015.50.2.113
© The Korean Society of Hematology
Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
1Hematology Division, Sant'Eugenio Hospital, Rome, Italy.
2Pathology Department, Sant'Eugenio Hospital, Rome, Italy.
Correspondence to : Correspondence to Pasquale Niscola. Hematology Division, S. Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy. pniscola@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PDF
Standard view
Export citation
Share Article
Letter to the Editor
Blood Res 2015; 50(2): 113-114
Published online June 25, 2015 https://doi.org/10.5045/br.2015.50.2.113
Copyright © The Korean Society of Hematology.
Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
Pasquale Niscola1*, Andrea Tendas1, Laura Scaramucci1, Marco Giovannini1, Stefano Fratoni2, and Paolo de Fabritiis1
1Hematology Division, Sant'Eugenio Hospital, Rome, Italy.
2Pathology Department, Sant'Eugenio Hospital, Rome, Italy.
Correspondence to: Correspondence to Pasquale Niscola. Hematology Division, S. Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy. pniscola@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Previous Article
